查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009331

奈米孔技術市場規模、佔有率、趨勢和預測：按產品、應用、最終用戶和地區分類，2026-2034年

Nanopore Technologies Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2025年全球奈米孔技術市場規模為3.418億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到8.348億美元，2026年至2034年的複合年成長率（CAGR）為10.12%。目前，北美市場主導地位，預計2025年市佔率將超過41.2%。全球市場成長的主要促進因素包括：對精準醫療和即時、經濟高效的DNA/RNA定序的需求不斷成長；在診斷和藥物研發領域的應用日益廣泛；定序準確性和便攜性的提高；研發投入的增加；以及在基因組學、蛋白質組學和個人化醫療解決方案領域的應用日益普及。

由於奈米孔技術能夠實現DNA和RNA的即時、低成本定序，全球市場的主要驅動力是精準醫療和基因分析需求的不斷成長。此外，該技術在診斷工具、藥物研發和個人化醫療等領域的應用不斷拓展，也推動了市場成長。定序準確性的持續提升、成本的降低以及通量能力的提高，進一步提振了奈米孔技術市場的前景。同時，對快速攜帶式診斷方法日益成長的需求，以及基因組學和蛋白​​質組學領域的持續研究，加上不斷增加的研發投入，共同促進了市場擴張。例如，2025年1月13日，Truveta宣布獲得來自Regeneron Pharmaceuticals、Illumina和17家美國醫療機構的3.2億美元投資，用於建立全球最大的基因資料庫。該計畫旨在收集1000萬個基因組序列，以改善藥物研發和患者照護。 Regeneron將投資1.2億美元進行定序，Illumina將投資2,000萬美元。該計畫預計將透過納入匿名化的醫療記錄和經患者同意的檢體，擴大規模和多樣性。

美國作為重要的區域市場脫穎而出，這主要歸因於癌症和心血管疾病等慢性病的日益普及。例如，根據美國食品藥物管理局（FDA）的數據，美國十大死因中有七種是常見慢性病（CCD），其中與飲食相關的疾病，如心血管疾病、糖尿病、肥胖和某些癌症，佔了相當大的比例。美國在飲食相關疾病的盛行率方面落後於42個國家，而且仍有2800萬美國人吸煙，這增加了對獨特治療性介入的需求。微生物學和環境監測領域的研究活動日益增多，奈米孔裝置被用於檢測病原體和污染物。此外，人工智慧與奈米孔技術的融合正在提高數據分析和診斷的準確性。同時，醫療和農業領域對快速、高效和現場檢測的需求也促進了市場成長。該國強大的醫療基礎設施和政府對生物技術創新的有利支持，進一步加速了奈米孔技術的應用。

奈米孔技術市場的發展趨勢：

臨床應用領域的拓展

由於奈米孔定序能夠即時定序長鏈DNA和RNA，因此在臨床診斷領域正日益受到重視。其革命性的潛力體現在感染疾病診斷方面，能夠加速病原體鑑定並顯著改善患者預後。奈米孔技術在癌症基因組學領域的應用也日益廣泛，能夠分析結構變異、甲基化模式和基因融合等對制定個人化治療策略至關重要的資訊。 2024年9月發表的一項研究探討了牛津奈米定序在評估醫院內感染疾病傳播風險的應用，但並未提供使用該技術的醫院數量數據。 2024年6月發表的另一項研究則著重於紐西蘭一家四級醫療機構的奈米孔定序基準測試和品管，顯示該技術正在特定醫療機構中得到應用。與傳統定序相比，奈米孔技術無需擴增或大規模樣本製備，因此在臨床應用中效率更高。其多功能性和不斷降低的成本正使奈米孔定序成為精準醫療的核心技術。該技術能夠適應不斷變化的醫療需求，例如疫情監測和抗生素抗藥性管理，這進一步凸顯了其革新臨床應用和推動奈米孔技術市場持續成長的潛力。

攜帶式的進步

奈米孔技術正透過攜帶式定序設備的快速發展，徹底改變基因分析的便利性和可近性。牛津奈米孔公司的「MinION」定序儀因其小巧的體積、經濟的價格以及即時交付定序結果的功能而廣受歡迎。截至2023年，MinION設備已在全球100多個國家使用，展現了其卓越的全球普及度。由於這些行動裝置，研究人員和醫療保健專業人員現在可以在各種環境下進行基因分析，包括偏遠地區和資源匱乏的環境。這種便攜性對於田間病原體監測、農業基因組學和環境監測等應用尤其重要，因為在這些應用中，在現場建立完整的實驗室並不現實。此外，將行動裝置與基於雲端的分析平台整合，可增強其功能，並實現即時數據共用和協作。對開發方便用戶使用且功能強大的設備的日益重視，正在使定序技術更加普及，並擴大奈米孔技術的市場佔有率。

加大基因組研究的投資

除了私人企業外，各國政府、學術機構和個人對基因組研究的投入不斷增加，正在成長要素。最新數據顯示，美國國立衛生研究院 (NIH) 已撥款高達 2700 萬美元用於構建利用基因組分析的學習型醫療保健系統，其中第一年就累計540 萬美元用於將基因組分析整合到患者照護中。這些措施表明，人們越來越關注利用奈米孔定序平台等先進定序技術來改善醫療效果。這些投資有望加深我們對遺傳訊息本質及其對健康、農業和環境科學意義的理解。諸如人類基因組計劃以及美國和中國等國家的國家基因組研究項目等資助舉措正在推動定序技術的創新，包括基於奈米孔的測序平台。私人企業也投入大量資源開發尖端的奈米孔定序設備，以滿足對更快、更低成本、更精確的定序解決方案日益成長的需求。資金的湧入正在加速技術進步，並催生個人化醫療和合成生物學等領域的新應用。研究經費的穩定成長凸顯了奈米孔技術在更廣泛的基因組學生態系統中發揮的關鍵作用。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球奈米孔技術市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 裝置
    • 主要部分
      • 可攜式的
      • 工作檯面
  • 消耗品

第7章 市場區隔：依應用領域分類

  • DNA定序
  • RNA定序
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院和診所
  • 研究機構
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Agilent Technologies Inc.
    • Cyclomics BV
    • Electronic Biosciences Inc.
    • Inanobio Inc.
    • Nabsys Inc.
    • Ontera Inc.
    • Oxford Nanopore Technologies Limited
    • Pacific Biosciences of California Inc.
    • Quantapore Inc.
    • Roche Holding AG
    • Tracxn Technologies Limited
Product Code: SR112026A4718

The global nanopore technologies market size was valued at USD 341.8 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 834.8 Million by 2034, exhibiting a CAGR of 10.12% during 2026-2034. North America currently dominates the market, holding a significant market share of over 41.2 % in 2025. The global market is majorly driven by rising demand for precision medicine, real-time and cost-effective DNA/RNA sequencing, expanding applications in diagnostics and drug discovery, advancements in sequencing accuracy and portability, increasing research investments, and growing adoption in genomics, proteomics, and personalized healthcare solutions.

The global market is primarily driven by the increasing demand for precision medicine and genetic analysis as nanopore technology offers real-time, cost-effective sequencing of DNA and RNA. Moreover, the growing applications in diagnostic tools, drug discovery, and personalized medicine are fueling market growth. Additionally, ongoing advancements in sequencing accuracy, reduced costs, and improved throughput capabilities are further creating a positive nanopore technologies market outlook. Moreover, the rising need for rapid, portable diagnostics and the ongoing efforts in the fields of genomics and proteomics are also contributing to the market's expansion, along with increased research investments. For instance, on January 13, 2025, Truveta announced a USD 320 Million investment from Regeneron Pharmaceuticals, Illumina, and 17 U.S. health systems to create the world's largest genetic database. This initiative aims to compile 10 million genomic sequences, enhancing drug discovery and patient care. Regeneron will contribute USD 120 Million and conduct the sequencing, while Illumina will invest USD 20 Million. The project will extend this work in scale and diversity to include patient-consented, anonymized medical records and specimens.

The United States stands out as a key regional market, primarily driven by the prevalence of chronic diseases such as cancer and cardiovascular conditions is rising. For instance, U.S. Food & Drug Administration reported that seven of the ten major causes of death in the U.S. are common chronic diseases (CCDs), with diet-related illnesses such as cardiovascular disease, diabetes, obesity, and certain cancers contributing significantly. The U.S. ranks behind 42 countries in diet-related disease rates, and 28 million Americans continue to smoke, which is fueling the need for unique therapeutic intervention. increasing research activities in the areas of microbiology and environmental monitoring where nanopore devices are used for the detection of pathogens and contaminants. In addition, the integration of artificial intelligence with nanopore technology is improving the data analysis and the diagnostic accuracy. Furthermore, the healthcare and agricultural sector demands immediate, efficient, and on-site tests, which is contributing to market growth. The country's strong healthcare infrastructure and favorable government initiatives for the support of biotech innovations are accelerating the adoption of nanopore technologies further.

NANOPORE TECHNOLOGIES MARKET TRENDS:

Expanding Clinical Applications

Nanopore sequencing is increasingly becoming popular in clinical diagnostics as it has the capability to sequence long DNA or RNA strands in real-time. Its transformative power is in infectious disease diagnostics, where pathogen identification becomes faster and greatly improves patient outcome. Applications in cancer genomics are increasing as nanopore technologies enable the analysis of structural variants, methylation patterns, and gene fusions that are important for the formulation of personalized treatment strategies. A study published in September 2024 discusses the application of Oxford Nanopore sequencing to assess the possible transmission of infections within a hospital setting, but it does not provide data on the number of hospitals using the technology. Another study from June 2024 focuses on benchmarking and quality control for nanopore sequencing in a single quaternary hospital in New Zealand, indicating that the technology is being implemented in specific institutions. In contrast to conventional sequencing, nanopore technology does not require amplification or extensive sample preparation, making it very efficient for clinical use. Its versatility and declining costs are setting nanopore sequencing as a core technology in precision medicine. The adaptability of the technology to address emerging healthcare needs, such as monitoring pandemics and managing antimicrobial resistance, further emphasizes its potential to revolutionize clinical applications and drive sustained nanopore technologies market growth.

Advancements in Portable Devices

Nanopore technologies are revolutionizing the accessibility and usability of genetic analysis through rapid developments in portable sequencing devices. The Oxford Nanopore's MinION has been popular in its compact form, affordability, and real-time delivery of sequencing results. As of 2023, the MinION device has been used in over 100 countries, highlighting its global reach. Researchers and healthcare providers are empowered by these portable devices to conduct onsite genetic analyses within diverse environments- remote and resource limited. This portability is significantly beneficial in applications such as field-based pathogen surveillance, agricultural genomics, and environmental monitoring as it is impractical to set up a whole laboratory in the field. Besides that, the integration of cloud-based analysis platforms with portable devices tends to enhance their functionality, allowing real-time data sharing and collaboration. The increasing emphasis on the development of user-friendly and robust devices is democratizing access to sequencing technologies, expanding nanopore technologies market share.

Rising Investments in Genomic Research

Increasing investment by governments and academic institutions, in addition to private enterprises, into genomic research is a growth factor for the nanopore technologies market. According to recent data, the National Institutes of Health (NIH) has allocated up to USD 27 Million to establish genomics-enabled learning health systems and has earmarked USD 5.4 Million for the first year to integrate genomics into patient care. These initiatives underscore the growing emphasis on leveraging advanced sequencing technologies, such as nanopore platforms, for improving healthcare outcomes. These investments are expected to help better understand the nature of genetic information and what that might mean for health, agriculture, and environmental sciences. Funding initiatives such as the Human Genome Project and national genomic research programs in countries such as the U.S. and China are fueling innovation in sequencing technologies, including nanopore-based platforms. Private-sector players are also channeling significant resources into the development of cutting-edge nanopore devices to meet the rising demand for faster, cheaper, and more accurate sequencing solutions. This influx of funding is accelerating technological advancements and enabling new applications in personalized medicine, synthetic biology, and more. The steady growth in research funding underscores the pivotal role nanopore technologies play in the broader genomics ecosystem.

NANOPORE TECHNOLOGIES INDUSTRY SEGMENTATION:

Analysis by Product:

  • Instruments
    • Portable
    • Benchtop
  • Consumables

Consumables lead the market with around 55.0% of market share in 2025. The dominance of consumables in the nanopore technologies market is driven by the recurring demand for sequencing processes, such as flow cells, reagents, and sample preparation kits. These are essential components that ensure the performance and accuracy of nanopore devices, and thus, research institutions, healthcare providers, and diagnostic labs continue to purchase them. The growing need for personalized medicine and real-time sequencing applications ensures the sustained demand for consumables in the nanopore technologies market. Moreover, consumable design is being improved, with higher throughput flow cells and specialized reagents that are improving efficiency and lowering costs, which further increases adoption.

Analysis by Application:

  • DNA Sequencing
  • RNA Sequencing
  • Others

DNA sequencing leads the market with around 60.0% of market share in 2025. DNA sequencing plays a vital role in the nanopore technologies market as it gives real-time and long-read sequences that provide invaluable information about genetics. Moreover, the technology is cost-effective and portable for wide use in research and clinic settings, thereby making the nanopore market valuable. These are especially applied in the determination of complex variations, structural rearrangements, and epigenetic modifications. The growing demand for precision medicine and improvements in the speed and accuracy of sequencing will further support the application of this technology in the diagnosis of diseases, personalized treatment, and studies of evolution. Also, the greater integration of nanopore DNA sequencing in agriculture and microbiology strengthens its market leadership.

Analysis by End User:

  • Hospitals and Clinics
  • Research Institutes
  • Others

Research institutes lead the market with around 45.3% of market share in 2025. The market for nanopore technologies is dominated by research institutes due to the substantial contribution these institutes have toward genomic studies, molecular biology, and biotechnology. These institutes significantly apply nanopore sequencing to diverse applications such as genetic mutations, rare diseases, and the study of microbiomes. This nanopore platform's flexibility and scalability provide advanced research capabilities in areas such as transcriptomics and epigenetics. The development of grants and government funding for scientific research also increases adoption, together with cooperation by a large number of research institutes, which implements innovation through improved sequencing accuracy and efficiency, resulting in their dominant position in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 41.2% due to its superior healthcare infrastructure and substantial investments in biotechnology and genomic research. The region benefits from the presence of key industry players and has vast government funding for precision medicine and genomics. Furthermore, the acceptance of innovative technologies, including real-time sequencing and AI integration, is also speeding up the growth of the market. The demand from individualized medicines, diagnostics, agricultural, and environmental sectors forms further support for the market.

KEY REGIONAL TAKEAWAYS:

UNITED STATES NANOPORE TECHNOLOGIES MARKET ANALYSIS

In 2025, the US accounted for around 78.90% of the total North America nanopore technologies market. The U.S. nanopore technologies market is rising fast with immense investment in genomics and healthcare innovations. The NIH has granted up to USD 27 Million to create a network of genomics-enabled learning health systems and allocated USD 5.4 Million for the first year to embed genomics in patient care. All these efforts are enriching the application of nanopore-based sequencing in real-time clinical decision-making and disease management. Companies such as Oxford Nanopore Technologies are seizing the momentum with high-end, low-cost sequencing solutions. Market growth is driven by precision medicine and increased funding in genomic research. Through its collaborations with industries and the supportive role of the U.S. government towards innovative biotechnology activities, the United States is establishing its position as one of the global leaders in nanopore technologies.

EUROPE NANOPORE TECHNOLOGIES MARKET ANALYSIS

The nanopore technologies market in Europe is growing steadily with the rise in investments in genomic research and healthcare initiatives. Eurostat statistics revealed that the EU has set aside EUR 1.8 Billion (USD 1.9 Billion) in 2022 toward biotech innovation, most of which targets nanopore sequencing. The UK and Germany are the leaders, and institutions such as the Francis Crick Institute drive cutting-edge research. The adoption of nanopore technologies in next-generation sequencing is also on the rise in clinical diagnostics, especially in rare diseases. Moreover, personalized medicine has become a major emphasis in the EU, such as through Horizon Europe, further fostering nanopore technologies market demand. . With biotech growth being supported by regulatory frameworks, Europe will be an excellent player in the global market of nanopore technology.

ASIA PACIFIC NANOPORE TECHNOLOGIES MARKET ANALYSIS

The Asia Pacific nanopore technologies market is growing rapidly due to increased investments in genomics and healthcare advancement. Chinese nanopore sequencing company Qitan Tech raised a Series C round of RMB 700 Million (or about USD 103.7 Million) back in January 2023. This is significant private sector interest in the area. Countries such as China and India have focused heavily on genomic research and clinical applications, with initiatives such as "Make in India" enhancing domestic innovation in sequencing technologies. Further pushing market growth will be the increasing interest in personalized medicine and infectious disease detection in Japan and South Korea. Acceleration of innovation through collaborative partnerships between local and global players, increased government funding, and development of healthcare infrastructure are making the region a significant contributor to the global nanopore technologies market.

LATIN AMERICA NANOPORE TECHNOLOGIES MARKET ANALYSIS

Latin American nanopore technologies are growing with investments in genomics and biotechnology. For example, the National Fund for Scientific and Technological Development in Brazil was given more resources in the 2023 fiscal year according to Law No. 14.577 by Global Trade Alert. These resources support scientific research and innovation, including advancements in genomics. Countries such as Mexico and Colombia are also focusing on genomic research for regional health challenges, which is propelling the demand for innovative sequencing technologies. Private investments along with government initiatives are encouraging the collaboration of local researchers with international players, which will fuel the market growth. Further, the developing healthcare infrastructure along with the increased focus on precision medicine is emerging Latin America as a new hub in the global nanopore technologies market.

MIDDLE EAST AND AFRICA NANOPORE TECHNOLOGIES MARKET ANALYSIS

Nanopore technologies market in the Middle East and Africa is picking up as more investment in healthcare innovation takes place. For instance, the UAE's federal budget for 2023 had AED 63.066 Billion, or about USD 17.17 Billion, allocated to total expenditures. Of that amount, AED 4.8 Billion, or about USD 1.31 Billion, was allocated to healthcare and community protection (Ministry of Finance). The Emirati Genome Program also focuses on the complete sequencing of the Emirati genome to improve personalized healthcare. All these programs indicate the heavy incorporation of cutting-edge genomic technology within the health sector. Collaboration with international biotech companies and increasing investment in sequencing technologies in precision medicine is driving growth in the market. Expanding health infrastructure and government-sponsored research programs put the region as a fast-growing contributor to the global landscape of nanopore technologies.

COMPETITIVE LANDSCAPE:

The market is characterized by the presence of numerous established players and emerging innovators striving to enhance sequencing technologies. Companies are heavily investing in research and development to improve accuracy, throughput, and affordability, fostering a dynamic environment of technological advancements. Strategic partnerships, licensing agreements, and collaborations with academic institutions are prevalent, facilitating innovation and expanding application areas. In addition, market participants are focusing on miniaturization and portability of devices, catering to the rising demand for point-of-care diagnostics and field-based testing solutions across various sectors. Notably, on November 5, 2024, Oxford Nanopore Technologies announced its partnership with UK health agencies to speed up pathogen screening across up to 30 NHS sites. The partnership will identify severe respiratory infections and recommend treatments within six hours of sample collection, thus bolstering early warning systems for pandemic threats. Oxford Nanopore's long-read sequencing technology will be used in the project to improve monitoring of emerging bacterial and viral threats and the spread of drug-resistant pathogens.

The report provides a comprehensive analysis of the competitive landscape in the nanopore technologies market with detailed profiles of all major companies, including:

  • Agilent Technologies Inc.
  • Cyclomics BV
  • Electronic Biosciences Inc.
  • Inanobio Inc.
  • Nabsys Inc.
  • Ontera Inc.
  • Oxford Nanopore Technologies Limited
  • Pacific Biosciences of California Inc.
  • Quantapore Inc.
  • Roche Holding AG
  • Tracxn Technologies Limited

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the nanopore technologies market?

2. What is the future outlook of nanopore technologies market?

3. What are the key factors driving the nanopore technologies market?

4. Which region accounts for the largest nanopore technologies market share?

5. Which are the leading companies in the global nanopore technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nanopore Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Portable
      • 6.1.2.2 Benchtop
    • 6.1.3 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 DNA Sequencing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 RNA Sequencing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Cyclomics BV
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Electronic Biosciences Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Inanobio Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Nabsys Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ontera Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Oxford Nanopore Technologies Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pacific Biosciences of California Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Quantapore Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Roche Holding AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Tracxn Technologies Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Nanopore Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Nanopore Technologies Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Nanopore Technologies Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Nanopore Technologies Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Nanopore Technologies Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Nanopore Technologies Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Nanopore Technologies (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Nanopore Technologies (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Nanopore Technologies (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Nanopore Technologies (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Nanopore Technologies (DNA Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Nanopore Technologies (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Nanopore Technologies (RNA Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Nanopore Technologies (RNA Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Nanopore Technologies (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Nanopore Technologies (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Nanopore Technologies (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Nanopore Technologies (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Nanopore Technologies (Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Nanopore Technologies (Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Nanopore Technologies (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Nanopore Technologies (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Nanopore Technologies Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Nanopore Technologies Industry: SWOT Analysis
  • Figure 74: Global: Nanopore Technologies Industry: Value Chain Analysis
  • Figure 75: Global: Nanopore Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nanopore Technologies Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Nanopore Technologies Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Nanopore Technologies Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Nanopore Technologies Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Nanopore Technologies Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Nanopore Technologies Market: Competitive Structure
  • Table 7: Global: Nanopore Technologies Market: Key Players